Last checked at Today 09:48
LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News1
GSK Share
Chat2
GSK Share
Trades3,364
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,700.00
Bid:
1,699.50
Ask:
1,700.50
Change:
-5.00 (-0.29%)
Spread:
1.00 (0.059%)
Open:
1,705.00
High:
1,711.00
Low:
1,695.50
Prev. Close:
1,705.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.London midday: Mining rebound lifts markets higher
Fri, 19th Apr 2013 11:57
The FTSE 100 rebound on Friday morning after a five-day losing streak as strong gains in the mining sector lifted London's benchmark higher."Clients who went bargain hunting in the mining space after the aggressive sell-off earlier in the week have been rewarded this morning, as the sector bounces back strongly early on," said Matt Basi, the Head of UK Sales Trading at CMC Markets.Ahead of today's session, the FTSE 100 had lost 2.7% of its value after five consecutive falls as disappointing US earnings and concerns over global growth weighed on sentiment.First-quarter economic gross domestic product figures from China, a plummeting gold price and downwards revisions to global growth forecasts by the International Monetary Fund caused some volatile swings in the mining sector earlier this week. Before today, FTSE 350 mining stocks had fallen by an average 9.14% since last Friday.FTSE 100: Miners provide a liftMining stocks were performing well after a volatile week for the sector. ENRC, Vedanta, EVRAZ and Randgold were all making decent gains by lunchtime.Anglo American was also a high riser after announcing that production at its larger operations of iron ore and copper increased in the first quarter, when compared with last year, despite the company scaling back spending.Meanwhile, telecoms firm Vodafone was also in demand as rumours continue to circulate surrounding a buy-out of its 45% stake in its US wireless joint venture with Verizon. According to reports this morning, a deal could happen this year as fears about tax obstacles ease.GlaxoSmithKline was trading lower ahead of its first-quarter update next week. There were reports this morning that the company is being investigated over claims it paid off firms to delay the launch of cheap versions of its anti-depression drug.FTSE 250: Spectris plummets after weak first quarterSpectris, the electrical engineering firm, plummeted after reporting an 8.0% fall in first-quarter sales, reflecting a deferral of orders and shipment delaysHigh Street bookie William Hill surged early on despite reporting that growth had moderated during the first quarter. The firm did say however that the Grand National after the quarter-end was a "major success", beating its record win achieved on the race in 2009.Online information and events group Euromoney fell after announced that it has acquired a 75% stake in the Australian provider of investment forums, Centre for Investor Education.
More News
1 May 2024 19:39
Bird flu testing shows more dairy products are safe, US FDA says
CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.
Read more1 May 2024 17:31
UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh
FTSE 100 down 0.3%, FTSE 250 off 0.2%
*Read more1 May 2024 16:56
LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision
(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.
Read more1 May 2024 16:42
London close: Stocks fall ahead of US Fed decision
(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.
Read more1 May 2024 11:55
LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage
(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.
Read more1 May 2024 10:54
GSK raises profit outlook on strong vaccine, HIV drug sales
FY profit forecast raised to 8-10%
*Read more1 May 2024 08:57
LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed
(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.
Read more1 May 2024 08:50
TOP NEWS: GSK expects momentum to continue after strong first quarter
(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.
Read more1 May 2024 07:46
LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast
(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.
Read more1 May 2024 07:36
GSK lifts annual guidance on strong virus treatment sales
(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.
Read more30 Apr 2024 23:46
First trial over Zantac cancer claims set to begin in Chicago
April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.
Read more30 Apr 2024 22:39
First trial over Zantac cancer claims set to begin in Chicago
April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.
Read more30 Apr 2024 13:51
Sensodyne maker Haleon to shut UK factory with loss of 435 jobs
(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.
Read more30 Apr 2024 12:22
Sensodyne-maker Haleon to shut UK plant, 435 jobs to go
April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.
Read more